Streptococcus Pneumoniae

CDC assesses susceptibility testing practices in U.S.

Published in Medical Letter on the CDC and FDA, June 9th, 2002

Antimicrobial resistance is rapidly changing for pneumococci, and recommendations for susceptibility testing probably will continue to change, according to new data in the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report (May 10, 2002;51(RR-6)).

Most clinical laboratories surveyed in February 2000 were using appropriate methods for pneumococcal susceptibility testing; however, some inconsistencies with the National Committee for Clinical Laboratory Standards (NCCLS) guidelines were noted.

For isolates from patients with potentially life-threatening infections, laboratories should bypass oxacillin disk...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2002-06-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry